PH17981A - Nonapeptide for the treatment of drug withdrawal symtoms - Google Patents
Nonapeptide for the treatment of drug withdrawal symtomsInfo
- Publication number
- PH17981A PH17981A PH27299A PH27299A PH17981A PH 17981 A PH17981 A PH 17981A PH 27299 A PH27299 A PH 27299A PH 27299 A PH27299 A PH 27299A PH 17981 A PH17981 A PH 17981A
- Authority
- PH
- Philippines
- Prior art keywords
- nonapeptide
- treatment
- drug withdrawal
- symtoms
- withdrawal symtoms
- Prior art date
Links
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH330681 | 1981-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH17981A true PH17981A (en) | 1985-02-26 |
Family
ID=4253131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH27299A PH17981A (en) | 1981-05-21 | 1982-05-14 | Nonapeptide for the treatment of drug withdrawal symtoms |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US4444758A (h) |
| EP (1) | EP0065747B1 (h) |
| JP (1) | JPS5823630A (h) |
| AU (1) | AU552547B2 (h) |
| CA (1) | CA1188989A (h) |
| DE (1) | DE3218761A1 (h) |
| IE (1) | IE53395B1 (h) |
| IL (1) | IL65782A (h) |
| IT (1) | IT1152116B (h) |
| PH (1) | PH17981A (h) |
| ZA (1) | ZA823369B (h) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486599A (en) * | 1989-03-29 | 1996-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Construction and use of synthetic constructs encoding syndecan |
| US5403595A (en) * | 1991-05-07 | 1995-04-04 | Dynagen, Inc. | Controlled, sustained release delivery system for smoking cessation |
| US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
| US7220737B1 (en) | 1997-09-04 | 2007-05-22 | Novoneuron, Inc | Noribogaine in the treatment of pain and drug addiction |
| CA2302754C (en) | 1997-09-04 | 2011-11-08 | Novoneuron, Inc. | Noribogaine in the treatment of pain and drug addiction |
| TR200102265T2 (tr) * | 1999-02-05 | 2001-12-21 | The Victoria University Of Manchester | Anestezi düzenlemesi. |
| DE10014007A1 (de) * | 2000-03-22 | 2001-10-11 | Strathmann Ag & Co | Neue Darreichungsformen für DSIP |
| RU2005128993A (ru) * | 2005-09-08 | 2007-03-20 | Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) | Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний |
| EP2205266A2 (en) * | 2007-09-11 | 2010-07-14 | Mondobiotech Laboratories AG | Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| US8362007B1 (en) | 2010-05-11 | 2013-01-29 | Demerx, Inc. | Substituted noribogaine |
| US9394294B2 (en) | 2010-05-11 | 2016-07-19 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US8765737B1 (en) | 2010-05-11 | 2014-07-01 | Demerx, Inc. | Methods and compositions for preparing and purifying noribogaine |
| US9586954B2 (en) | 2010-06-22 | 2017-03-07 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| US8637648B1 (en) | 2010-06-22 | 2014-01-28 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8802832B2 (en) | 2010-06-22 | 2014-08-12 | Demerx, Inc. | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier |
| US8741891B1 (en) | 2010-06-22 | 2014-06-03 | Demerx, Inc. | N-substituted noribogaine prodrugs |
| MX2013000733A (es) | 2010-07-23 | 2013-05-30 | Demerx Inc | Composiciones de noribogaina. |
| EP2481740B1 (en) | 2011-01-26 | 2015-11-04 | DemeRx, Inc. | Methods and compositions for preparing noribogaine from voacangine |
| US9617274B1 (en) | 2011-08-26 | 2017-04-11 | Demerx, Inc. | Synthetic noribogaine |
| JP2015500833A (ja) | 2011-12-09 | 2015-01-08 | デメレックス， インコーポレイテッド | ノルイボガインのリン酸エステル |
| US9150584B2 (en) | 2012-01-25 | 2015-10-06 | Demerx, Inc. | Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| AU2013212139A1 (en) | 2012-01-25 | 2014-06-26 | Demerx, Inc. | Synthetic voacangine |
| US8940728B2 (en) | 2012-12-20 | 2015-01-27 | Demerx, Inc. | Substituted noribogaine |
| US9045481B2 (en) | 2012-12-20 | 2015-06-02 | Demerx, Inc. | Substituted noribogaine |
| EP2934541A4 (en) | 2012-12-20 | 2016-08-03 | Demerx Inc | NORIBOGAINE SUBSTITUTE |
| CA2989550C (en) | 2014-06-18 | 2023-08-08 | Demerx, Inc. | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH634331A5 (de) * | 1977-06-30 | 1983-01-31 | Hoffmann La Roche | Phosphorylierte nonapeptide und verfahren zu deren herstellung. |
-
1982
- 1982-04-21 CA CA000401386A patent/CA1188989A/en not_active Expired
- 1982-05-04 IT IT21072/82A patent/IT1152116B/it active
- 1982-05-14 PH PH27299A patent/PH17981A/en unknown
- 1982-05-14 IL IL65782A patent/IL65782A/xx not_active IP Right Cessation
- 1982-05-14 ZA ZA823369A patent/ZA823369B/xx unknown
- 1982-05-17 AU AU83756/82A patent/AU552547B2/en not_active Expired
- 1982-05-17 US US06/379,162 patent/US4444758A/en not_active Expired - Lifetime
- 1982-05-18 DE DE3218761A patent/DE3218761A1/de active Granted
- 1982-05-18 EP EP82104367A patent/EP0065747B1/de not_active Expired
- 1982-05-19 JP JP57083370A patent/JPS5823630A/ja active Granted
- 1982-05-20 IE IE1214/82A patent/IE53395B1/en not_active IP Right Cessation
-
1984
- 1984-02-24 US US06/583,520 patent/US4496545A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5823630A (ja) | 1983-02-12 |
| IE821214L (en) | 1982-11-21 |
| JPH0354089B2 (h) | 1991-08-19 |
| DE3218761C2 (h) | 1993-05-06 |
| AU8375682A (en) | 1982-11-25 |
| IL65782A (en) | 1985-08-30 |
| US4496545A (en) | 1985-01-29 |
| AU552547B2 (en) | 1986-06-05 |
| IE53395B1 (en) | 1988-11-09 |
| IT1152116B (it) | 1986-12-31 |
| EP0065747B1 (de) | 1986-10-15 |
| EP0065747A1 (de) | 1982-12-01 |
| ZA823369B (en) | 1983-03-30 |
| IT8221072A0 (it) | 1982-05-04 |
| IL65782A0 (en) | 1982-08-31 |
| DE3218761A1 (de) | 1982-12-16 |
| US4444758A (en) | 1984-04-24 |
| CA1188989A (en) | 1985-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH17981A (en) | Nonapeptide for the treatment of drug withdrawal symtoms | |
| EG18268A (en) | Medicament for the treatment of inflammation of the eye | |
| IL64001A0 (en) | Blood treatment system | |
| DE3375712D1 (en) | System for externally treating the blood | |
| ZA82124B (en) | Bandage for administering beneficial drug | |
| DE3274187D1 (en) | Anti-inflammatory ophthalmic solution and process for preparing the same | |
| MY8500514A (en) | The treatment of aqueous systems | |
| GB2116042B (en) | Injector for medical uses | |
| HU178841B (en) | Cattle-leader for the prophylactic or therapeutic treatment of cattle | |
| DE3261760D1 (en) | Pharmaceutical compositions for the treatment of skin | |
| DE3273455D1 (en) | Fire-resistant support for the human body | |
| PH19173A (en) | The treatment of aqueous system | |
| GB2220352B (en) | Medicaments for the treatment of emesis | |
| GB9103278D0 (en) | Drug for the treatment of dermatitis | |
| GB2216414B (en) | Medicaments for the treatment of emesis | |
| JPS57139016A (en) | Burn patient medicine | |
| IL93242A0 (en) | Pharmaceutical preparation for the treatment of tonsillitis | |
| DE3272384D1 (en) | Medicinal composition for the treatment of certain neuroviroses | |
| ZA825302B (en) | Medicine for the treatment of diabetes | |
| EP0412938A3 (en) | System for the treatment of contactlenses | |
| ZA822176B (en) | Pharmaceutical compositions for the treatment of diabetes | |
| DE3366025D1 (en) | Medicine for the treatment of the neoplazic disease | |
| AP9000180A0 (en) | Pharmaceutical composition for the treatment of protozoal diseases | |
| JPS57153661A (en) | Therapeutic container | |
| AU1705783A (en) | Medicine for the treatment of the neoplazic disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Record of annual fee payments |
Year of fee payment: 12 |